Inside Track: Precision Partnering
A novel partnership takes aim at developing NGS companion diagnostics in oncology.
Read MorePosted by Elaine Sanchez Wilson | Aug 11, 2017 | Cancer, Molecular Diagnostics |
A novel partnership takes aim at developing NGS companion diagnostics in oncology.
Read MorePosted by Elaine Sanchez Wilson | Jul 11, 2017 | Cancer |
The company recently appointed Sir Bruce Ponder, FRCP, FMedSci, FRS, to provide unique research perspectives and clinical expertise.
Read MorePosted by Elaine Sanchez Wilson | Jul 11, 2017 | Cancer, Lung Cancer |
New single-use aspiration needles are designed to offer improved access, usability, and puncture of difficult-to-access lymph node targets.
Read MorePosted by Elaine Sanchez Wilson | Jun 26, 2017 | Cancer, Lung Cancer, Molecular Diagnostics |
FDA has granted premarket approval to Thermo Fisher Scientific for the first next-generation sequencing-based test that simultaneously screens tumor samples for biomarkers associated with three FDA-approved therapies for non-small cell lung cancer.
Read MorePosted by Elaine Sanchez Wilson | Jun 5, 2017 | Disease States |
A number of oncology centers have developed and implemented liquid biopsy tests not only for lung cancer, but for breast, colorectal, gynecologic, ovarian, prostate, and skin cancers as well.
Read More